Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / App Notes / 2016 / Automating the cytogenetics process

Automating the cytogenetics process

06/24/2016

Share

The cytogenetics laboratory at the Regional Hospital of Treviso performs tests in different fields of clinical medicine including cancer cytogenetics (onco-haematology and solid tumours) and postnatal tests to detect constitutional abnormalities. The laboratory analyses approximately 2200 cases per year.

Techniques employed and clinical indications
The main techniques employed are: karyotyping/chromosome analysis; fluorescence in situ hybridisation (FISH); and comparative genomic hybridisation (array-CGH).
Karyotyping
Classical cytogenetic analysis is carried out on peripheral blood, skin and bone marrow samples to detect constitutional and acquired abnormalities. The clinical indications for investigation of constitutional karyotype are:
  • Primary or secondary amenorrhoea or premature menopause
  • Sperm abnormalities, such as azoospermia or severe oligospermia
  • Clinically significant abnormal growth
  • Ambiguous genitalia
  • Abnormal clinical phenotype or dysmorphism
  • Multiple congenital abnormalities
  • Intellectual disability or developmental delay;
  • Suspected deletion/duplication syndrome
  • A malformed foetus or stillbirth of unknown aetiology
  • Third and subsequent consecutive miscarriages.

Couples with:

  • Chromosome abnormality or unusual variant detected at prenatal diagnosis
  • Unbalanced chromosome abnormality in the products of conception
  • Child with a chromosome abnormality
  • Infertility of unknown aetiology.
The clinical indications for investigation of acquired karyotype include: acute leukaemia; myelodysplasia; chronic myelogenous leukaemia; chronic myeloproliferative neoplasms; malignant lymphoma and lymphoproliferative disorders; and chronic lymphocytic leukaemia. Side volume for karyotyping is 850 cases/year.

FISH
FISH is employed on cytological samples (peripheral blood and bone marrow) and histological sections of solid tumours. Side volume for FISH is 1200 cases/year.

>> Download the full Application Note as PDF

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

‘How to Go Digital in Pathology’ LabPON whitepaper (made possible by Philips)

November 24, 2016

‘Bidirectional integration in digital pathology’ LabPON whitepaper (made possible by Philips)

November 24, 2016

Philips’ iSyntax for Digital Pathology

November 24, 2016

Philips IntelliSite Open Pathology Platform

November 24, 2016

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.